User banner image
User avatar
  • Lukas HARTL


Hartl L; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Gompelmann D; Szekeres T; Quehenberger P; Trauner M; Mandorfer M; Scheiner B; Reiberger T, 2021. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.  J Pers Med 11.

Jachs M; Binter T; Schmidbauer C; Hartl L; Strasser M; Laferl H; Hametner-Schreil S; Lindorfer A; Dax K; Stauber RE; Kessler HH; Bernhofer S; Maieron A; Loacker L; Bota S; Santonja I; Munda P; Mandorfer M; Peck-Radosavljevic M; Holzmann H; Gschwantler M; Zoller H; Ferenci P; Reiberger T, 2021. Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis.  United European Gastroenterol J 9(10):1119-1127

Königshofer P; Hofer BS; Brusilovskaya K; Simbrunner B; Petrenko O; Wöran K; Herac M; Stift J; Lampichler K; Timelthaler G; Bauer D; Hartl L; Robl B; Sibila M; Podesser BK; Oberhuber G; Schwabl P; Mandorfer M; Trauner M; Reiberger T, 2021. Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies.  Hepatology.

Pomej K; Scheiner B; Hartl L; Balcar L; Meischl T; Mandorfer M; Reiberger T; Müller C; Trauner M; Pinter M, 2021. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.  PLoS One 16(8):e0256544

Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Schwabl P; Stättermayer AF; Pinter M; Eigenbauer E; Quehenberger P; Trauner M; Reiberger T; Mandorfer M, 2021. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death.  Clin Gastroenterol Hepatol.

Hartl L; Semmler G; Hofer BS; Schirwani N; Jachs M; Simbrunner B; Bauer DJM; Binter T; Pomej K; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. COVID-19-Related Downscaling of In-Hospital Liver Care Decreased Patient Satisfaction and Increased Liver-Related Mortality.  Hepatol Commun 5(10):1660-1675

Jachs M; Binter T; Chromy D; Schalk H; Pichler K; Bauer D; Simbrunner B; Hartl L; Schmidbauer C; Mayer F; Strassl R; Mandorfer M; Gschwantler M; Reiberger T, 2021. Outcomes of an HCV elimination program targeting the Viennese MSM population.  Wien Klin Wochenschr 133(13-14):635-640

Semmler G; Pomej K; Bauer DJM; Balcar L; Simbrunner B; Binter T; Hartl L; Becker J; Pinter M; Quehenberger P; Trauner M; Mandorfer M; Lisman T; Reiberger T; Scheiner B, 2021. Safety of direct oral anticoagulants in patients with advanced liver disease.  Liver Int 41(9):2159-2170

Balcar L; Semmler G; Pomej K; Simbrunner B; Bauer D; Hartl L; Jachs M; Paternostro R; Bucsics T; Pinter M; Trauner M; Mandorfer M; Reiberger T; Scheiner B, 2021. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure.  United European Gastroenterol J 9(4):427-437

Hartl L; Elias J; Prager G; Reiberger T; Unger LW, 2021. Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease.  World J Gastroenterol 27(19):2281-2298

Hartl L; Jachs M; Desbalmes C; Schaufler D; Simbrunner B; Paternostro R; Schwabl P; Bauer DJM; Semmler G; Scheiner B; Bucsics T; Eigenbauer E; Marculescu R; Szekeres T; Peck-Radosavljevic M; Kastl S; Trauner M; Mandorfer M; Reiberger T, 2021. The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes.  Hepatol Int 15(5):1160-1173

Jachs M; Hartl L; Schaufler D; Desbalmes C; Simbrunner B; Eigenbauer E; Bauer DJM; Paternostro R; Schwabl P; Scheiner B; Bucsics T; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes.  Gut 70(9):1758-1767

Costa D; Simbrunner B; Jachs M; Hartl L; Bauer D; Paternostro R; Schwabl P; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T, 2021. Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.  J Hepatol 74(4):819-828

Publication list retrieved from NCBI using ImpactPubs